Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volulyte vs HSA in Cardiac Surgery
NCT01553617Phase 4Completed
- Sponsor
- Fresenius Kabi
- Start
- Oct 2012
- Primary completion
- Jan 2014
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hetastarch in hypovolemia, sponsored by Fresenius Kabi. Started Oct 2012; status: completed.
02
Drugs
hetastarch
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT01553617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01553617.